知镜 Cognispect · 医学文献与研究工作台

Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease.

Li J, Liu R, Wang W, Zhang T, Kong Y, Jiang Q, Meng D, Cui S, Zhu S.
The Journal of biological chemistry · 2026-08-11 · PMID 42580410

文献摘要

Diabetic kidney disease (DKD), a systemic metabolic disorder, leads to renal failure and increased cardiovascular risk. A central driver of its progression is glucolipotoxicity, which triggers renal tubular injury through mechanisms that remain incompletely defined. Here, we identify Mrpl50 as a critical mediator of glucolipotoxic damage. Mrpl50 expression is upregulated under metabolic stress and correlates with DKD progression. Mrpl50 deficiency in renal tubular cell attenuated glucolipotoxic damage, while its overexpression amplified inflammatory responses. Mechanistically, Mrpl50 drives renal inflammation via the hypoxia-inducible factor 1 alpha pathway. These findings establish Mrpl50 as a molecular sensor that discriminates true hypoxia from metabolically induced pseudo-hypoxia, thereby fine-tuning the hypoxia-inducible factor 1 alpha response to govern disease progression in DKD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。